Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/06/27/2905156/0/en/Quoin-Pharmaceuticals-Announces-International-Expansion-of-Ongoing-Clinical-Trials-for-Netherton-Syndrome.html
https://www.globenewswire.com/news-release/2024/06/25/2904131/0/en/Quoin-Pharmaceuticals-to-Sponsor-the-Foundation-for-Ichthyosis-Related-Skin-Types-FIRST-2024-National-Conference.html
https://www.globenewswire.com/news-release/2024/06/12/2897465/0/en/Quoin-Pharmaceuticals-Announces-Signing-of-Research-Agreement-with-University-College-Cork-UCC-Ireland.html
https://www.globenewswire.com/news-release/2024/05/09/2878773/0/en/Quoin-Pharmaceuticals-Provides-Corporate-Update-and-Announces-First-Quarter-2024-Financial-Results.html
https://www.globenewswire.com/news-release/2024/05/02/2874728/0/en/Quoin-Pharmaceuticals-to-Announce-First-Quarter-2024-Financial-Results-on-May-9-2024.html
https://www.globenewswire.com//news-release/2024/03/13/2845843/0/en/Quoin-Pharmaceuticals-Provides-Corporate-Update-and-Announces-Fourth-Quarter-and-2023-Financial-Results.html
https://www.globenewswire.com//news-release/2024/03/07/2842739/0/en/Quoin-Pharmaceuticals-Announces-Fourth-Quarter-and-2023-Financial-Results-and-Corporate-Update-Conference-Call-to-be-held-on-Thursday-March-14th-at-8-30-am-ET.html
https://www.globenewswire.com//news-release/2024/03/05/2840412/0/en/Quoin-Pharmaceuticals-Announces-Pricing-of-6-5-Million-Public-Offering.html
https://www.globenewswire.com//news-release/2024/03/04/2839532/0/en/Quoin-Pharmaceuticals-Announces-FDA-Clearance-to-Recruit-Teen-Subjects-into-Both-Ongoing-Netherton-Syndrome-Clinical-Studies.html
https://www.globenewswire.com//news-release/2024/02/08/2825976/0/en/Quoin-Pharmaceuticals-Files-U-S-and-International-Patent-Applications-for-Novel-Netherton-Syndrome-Combination-Product.html